כל המחקרים
גיוסחקירה טיפולית (שלב II)התערבותי

COMPARISON OF ZINC ACETATE DOSE REGIMENS (GALZIN VS. ET-700) FOR THE TREATMENT OF WILSON DISEASE: A PHARMACODYNAMIC 64CUCL2 PET/CT STUDY IN HEALTHY PARTICIPANTS

Wilson's disease is a rare genetic condition where the body cannot get rid of excess copper, causing it to build up and damage the liver and brain. Zinc tablets are commonly used to treat it because zinc stops the body from absorbing copper from food. This study compares an established zinc medicine called Galzin with a new version called ET-700, as well as an inactive dummy pill (placebo). Because doctors need to understand how these medicines work in a standard body first, the study is open to healthy adult volunteers. Participants take the study tablets and undergo blood and urine tests, along with specialised PET/CT scans. These scans use a tiny, safe amount of a copper tracer to show how much copper enters the liver. The goal is to find out which zinc treatment works best, paving the way for better future treatments.

במבט חטוף

סטטוס
גיוס
שלב
חקירה טיפולית (שלב II)
נותן חסות
Region Midtjylland
יעד הרשמה
36
התחל
02 Mar 2026

על מה המחקר הזה?

Wilson's disease is a rare inherited condition that stops the body from removing extra copper. We all need a tiny amount of copper from our diet to stay healthy, but people with Wilson's disease store too much of it. Over time, toxic levels build up in vital organs, particularly the liver and the brain, which can lead to serious health problems if left untreated. Zinc medicines are a standard, life-saving treatment. They encourage the gut to produce a natural protein that traps copper, allowing it to pass safely out of the body in bowel movements rather than entering the blood.

Although current zinc treatments work well, they often need to be taken three times a day on a strictly empty stomach. This schedule can be difficult for patients to follow, and the tablets can sometimes cause stomach aches and nausea. This clinical trial is testing a new zinc formulation, ET-700, to see how it compares to an existing zinc medicine (Galzin) and a dummy pill (placebo). Researchers want to find out if the new option can block copper just as effectively, which could lead to more convenient treatment options in the future.

To see exactly how these medicines behave without the complications of liver damage, researchers are conducting this study in healthy volunteers. Participants receive a specialised imaging scan called a PET/CT scan before and after taking the tablets. The scan uses a tiny, safe trace of radioactive copper, allowing doctors to take clear pictures of how much copper reaches the liver. By comparing the scans across the different groups, researchers can accurately measure how well each medicine works.

נקודות עיקריות

  • The trial compares a new zinc tablet (ET-700) with a standard treatment (Galzin) and a dummy pill.
  • The goal is to improve future treatments for people with Wilson's disease by finding easier ways to block copper.
  • The study is open to healthy adult volunteers aged 18 and over.
  • Specialised PET/CT scans are used to measure how much copper reaches the liver.
  • Taking part is completely voluntary, and your health will be closely monitored throughout.

מי עשוי להיות זכאי?

This study is looking for healthy adult volunteers aged 18 and older. Because the main goal is to see how the treatments work in a healthy digestive system and liver, participants should not have Wilson's disease or other significant long-term medical conditions.

Both men and women can join. Before taking part, the research team will carry out health checks, including blood and urine tests, to confirm you are in good general health and that it is safe for you to take part in the trial.

You may not be eligible if you take certain regular medicines, have a history of serious stomach, kidney, or liver problems, or if you are pregnant or breastfeeding. The study team will review your medical history in detail before you agree to join.

האם מחקר זה יכול להתאים לך?

ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.

  1. I am aged 18 or older.
  2. I am in good general health without chronic liver or kidney conditions.
  3. I do not have Wilson's disease.
  4. אני לא בהריון ולא מניקה.
  5. I am able and willing to attend all scheduled hospital visits and scans.
ענה על כל שאלה כדי לראות את התוצאה שלך.

מה כרוך בהשתתפות?

Taking part involves several visits to a specialist hospital or clinical research unit over a few weeks. At the start, you will have a health screening and your first PET/CT scan, which involves receiving a tiny injection of a copper tracer so doctors can photograph your liver. You will then be randomly assigned by a computer to take either Galzin, ET-700, or a placebo tablet for a set number of days. During this time, you will take your tablets as instructed and attend regular appointments for check-ups, blood tests, and urine collections to track your copper and zinc levels. At the end of the treatment period, you will have a second PET/CT scan to see how the medicine affected copper absorption. The research team will also check in on you afterwards to ensure you are feeling well.

סיכונים ותועלות פוטנציאליים

Because you are taking part as a healthy volunteer, you will not receive any direct medical benefit from the study medicines. However, your time and effort will help scientists develop better, easier treatments for people living with Wilson's disease. The most common side effects of zinc tablets are mild stomach upsets, such as indigestion, nausea, or cramps. The PET/CT scans involve a very low dose of radiation from the copper tracer, which is carefully calculated to remain within safe clinical research limits. You will be closely looked after by doctors throughout the study, and you are free to stop taking part at any time without having to give a reason.

מיקומים (1)

חלק מהמיקומים באתר הם משוערים. אנחנו עובדים על שיפור זה — אנא ודאו עם צוות הניסוי לפני הנסיעה.
  • —
    לא מאומת
    דנמרק

שאלות נפוצות

Why is this trial testing a Wilson's disease drug on healthy people?

Testing in healthy volunteers allows doctors to see how the medicine works in a normal, healthy body without interference from existing liver illness or other medications.

Is the radiation from the scan dangerous?

The PET/CT scan uses a very small, carefully controlled amount of a radioactive copper tracer. The radiation dose is low and considered safe for clinical research studies.

Will I be able to choose which tablet I take?

No. A computer randomly decides whether you receive Galzin, ET-700, or the placebo. This is done to keep the results fair and scientifically reliable.

What happens if the tablets upset my stomach?

Zinc tablets can occasionally cause mild indigestion or nausea. You will be closely monitored, and you should tell the study team immediately so they can support you.

Can I leave the study early if I change my mind?

Yes. Taking part is entirely voluntary, and you can withdraw from the trial at any point, for any reason, without your normal medical care being affected.

כיצד לגלות עוד

תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.

מעוניינים להשתתף?

רשום את התעניינותך

שתף את הפרטים שלך וצוות המחקר עבור "COMPARISON OF ZINC ACETATE DOSE REGIMENS (GALZIN VS. ET-700)…" ייצרו איתך קשר אם אתה עשוי להיות זכאי. תמיד התייעץ עם הרופא שלך לפני שאתה מסכים להשתתף.

דיון

דיון קהילתי

מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.